Olink

About:

Olink develops ground-breaking technologies for biomolecular analysis.

Website: https://www.olink.com/

Twitter/X: olinkproteomics

Description:

Olink Holding AB is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

Total Funding Amount:

$117M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Uppsala, Uppsala Lan, Sweden

Founded Date:

2004-01-01

Contact Email:

info(AT)olink.com

Founders:

Simon Fredriksson

Number of Employees:

51-100

Last Funding Date:

2023-01-18

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai